TGFB1 and obstructive sleep apnea syndrome: Given the demonstrated roles of cancer stem cells in resistance to various therapy modalities, such as conventional chemotherapy, radiotherapy, and molecular targeted therapy, these latter findings suggest that high TGFβ signalling in OSA, apart from promoting metastasis, could additionally contribute to patient mortality by driving therapy resistance [13].